SWLGX | VIGIX | SWLGX / VIGIX | |
Total Expense Ratio | 0.04 | 0.04 | 88% |
Annual Report Gross Expense Ratio | 0.04 | 0.04 | 88% |
Fund Existence | 8 years | 27 years | - |
Gain YTD | 12.228 | 12.593 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.98B | 324B | 1% |
Annual Yield % from dividends | 0.47 | 0.44 | 108% |
Returns for 1 year | 28.96 | 24.02 | 121% |
Returns for 3 years | 93.71 | 73.68 | 127% |
Returns for 5 years | 144.78 | 107.21 | 135% |
Returns for 10 years | N/A | 321.65 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ERHSX | 13.99 | 0.15 | +1.08% |
Eaton Vance Worldwide Health Sci R | |||
SBLYX | 79.31 | -0.05 | -0.06% |
ClearBridge Large Cap Growth I | |||
PEGEX | 21.35 | -0.02 | -0.09% |
PGIM Jennison Mid-Cap Growth R2 | |||
VLPCX | 16.24 | -0.09 | -0.55% |
Virtus Duff & Phelps Sel MLP & Engy C | |||
PSCMX | 17.23 | -0.15 | -0.86% |
Putnam Small Cap Value R6 |